Wyss Institute's iNodes team receives ARPA-H Sprint for Women's Health award to advance the first implantable immune organs to treat ovarian cancer.

The Wyss Institute at Harvard University has been awarded the ARPA-H Sprint for Women's Health award to develop implantable immune organs called "iNodes" for personalized immunotherapy to treat ovarian cancer. Ovarian cancer is often diagnosed at later stages, leading to poor outcomes, but iNodes aim to activate the immune system against tumors. This innovative approach could provide a new treatment option for women with ovarian cancer, addressing a significant unmet need in women's health research. [Extracted from the article]